{"id":45992,"date":"2022-07-08T18:01:36","date_gmt":"2022-07-08T16:01:36","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\/"},"modified":"2022-07-08T18:01:36","modified_gmt":"2022-07-08T16:01:36","slug":"global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\/","title":{"rendered":"Global Ankylosing Spondylitis Market to 2032 &#8211; Featuring AbbVie, Pfizer, Janssen Biotech and Novartis Among Others &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5574388\/ankylosing-spondylitis-as-market-insights?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=rm9zkl&amp;utm_campaign=1723715+-+Global+Ankylosing+Spondylitis+Market+to+2032+-+Featuring+AbbVie%2C+Pfizer%2C+Janssen+Biotech+and+Novartis+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Ankylosing Spondylitis (AS) &#8211; Market Insights, Epidemiology, and Market Forecast &#8211; 2032&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220708005405\/en\/1508350\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220708005405\/en\/1508350\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThis report delivers an in-depth understanding of the AS, historical and forecasted epidemiology as well as the AS market trends in the United States, , EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.\n<\/p>\n<p>\nThe Ankylosing Spondylitis market report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted 7MM market size from 2019 to 2032. The Report also covers current AS treatment practice, market drivers, market barriers, SWOT analysis, reimbursement and market access, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.\n<\/p>\n<p>\n<strong>Geography Covered<\/strong>\n<\/p>\n<ul>\n<li>\nThe United States\n<\/li>\n<li>\nEU5 (Germany, France, Italy, Spain, and the United Kingdom)\n<\/li>\n<li>\nJapan\n<\/li>\n<\/ul>\n<p>\n<strong>Study Period:<\/strong> 2019-2032\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nUCB\n<\/li>\n<li>\nAbbVie\n<\/li>\n<li>\nPfizer\n<\/li>\n<li>\nAstella\n<\/li>\n<li>\nAmgen\n<\/li>\n<li>\nPfizer\n<\/li>\n<li>\nJanssen Biotech\n<\/li>\n<li>\nPozen\n<\/li>\n<li>\nNovartis\n<\/li>\n<li>\nIroko Pharmaceuticals\n<\/li>\n<li>\nSyntex Pharmaceuticals\n<\/li>\n<li>\nHorizon Pharma\n<\/li>\n<li>\nEli Lilly and Company\n<\/li>\n<li>\nKyowa Kirin\n<\/li>\n<li>\nCelgene\n<\/li>\n<li>\nInmagene Biopharmaceuticals\n<\/li>\n<\/ul>\n<p>\n<strong>Key Findings<\/strong>\n<\/p>\n<ul>\n<li>\nThe market size of Ankylosing Spondylitis (AS) in the 7MM was USD 4,200 million in 2021.\n<\/li>\n<li>\nIn 2021, the market size of AS in the US was 3,224 which is the highest among the 7MM countries.\n<\/li>\n<li>\nThe total current market of AS is calculated based on the characterization of the current market into three segments: conventional therapies, biologics, and Cox Inhibitors. It has been estimated that majority of the patients are recommended the use of biologics, as compared to other class drugs.\n<\/li>\n<li>\nFrom various clinical studies it has been observed that AS involves medication, exercise, physical therapy, good posture practices, and other options such as applying heat\/cold to help relax muscles and reduce joint pain. In severe cases, posture correcting surgery may also be an option.\n<\/li>\n<\/ul>\n<p>\n<strong>Scope of the Report<\/strong>\n<\/p>\n<ul>\n<li>\nThe report covers the descriptive overview of AS, explaining its causes, symptoms, pathophysiology, genetic basis, and currently available therapies.\n<\/li>\n<li>\nComprehensive insight has been provided into the AS epidemiology and treatment.\n<\/li>\n<li>\nAdditionally, an all-inclusive account of both the current and emerging therapies for AS is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape.\n<\/li>\n<li>\nA detailed review of the AS market; historical and forecasted is included in the report, covering the United States drug outreach.\n<\/li>\n<li>\nThe report provides an edge while developing business strategies, by understanding trends shaping and driving the United States AS market.\n<\/li>\n<\/ul>\n<p>\n<strong>Report Highlights<\/strong>\n<\/p>\n<ul>\n<li>\nThe robust pipeline with novel MOA and oral ROA, increasing incidence, effectiveness of drugs as both mono and combination therapy will positively drive the AS market.\n<\/li>\n<li>\nThe companies and academics are working to assess challenges and seek opportunities that could influence AS R&amp;D. The therapies under development are focused on novel approaches to treat\/improve the disease condition.\n<\/li>\n<li>\nMajor players are involved in developing therapies for AS. The launch of emerging therapies will significantly impact the AS market.\n<\/li>\n<li>\nOur in-depth analysis of the pipeline assets across different stages of development (phase III and phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities.\n<\/li>\n<\/ul>\n<p>\n<strong>Ankylosing Spondylitis (AS) Report Insights<\/strong>\n<\/p>\n<ul>\n<li>\nPatient Population\n<\/li>\n<li>\nTherapeutic Approaches\n<\/li>\n<li>\nAS Pipeline Analysis\n<\/li>\n<li>\nAS Market Size and Trends\n<\/li>\n<li>\nMarket Opportunities\n<\/li>\n<li>\nImpact of upcoming Therapies\n<\/li>\n<\/ul>\n<p>\n<strong>Ankylosing Spondylitis (AS)Report Key Strengths<\/strong>\n<\/p>\n<ul>\n<li>\n11 Years Forecast\n<\/li>\n<li>\n7MM Coverage\n<\/li>\n<li>\nAS Epidemiology Segmentation\n<\/li>\n<li>\nKey Cross Competition\n<\/li>\n<li>\nHighly Analyzed Market\n<\/li>\n<li>\nDrugs Uptake\n<\/li>\n<\/ul>\n<p>\n<strong>Ankylosing Spondylitis (AS) Report Assessment<\/strong>\n<\/p>\n<ul>\n<li>\nCurrent Treatment Practices\n<\/li>\n<li>\nUnmet Needs\n<\/li>\n<li>\nPipeline Product Profiles\n<\/li>\n<li>\nMarket Attractiveness\n<\/li>\n<li>\nMarket Drivers and Barriers\n<\/li>\n<li>\nSWOT analysis\n<\/li>\n<\/ul>\n<p>\n<strong>Reasons to Buy<\/strong>\n<\/p>\n<ul>\n<li>\nThe report will help in developing business strategies by understanding trends shaping and driving AS.\n<\/li>\n<li>\nTo understand the future market competition in the AS market and Insightful review of the key market drivers and barriers.\n<\/li>\n<li>\nOrganize sales and marketing efforts by identifying the best opportunities for AS in the 7MM countries.\n<\/li>\n<li>\nIdentification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors.\n<\/li>\n<li>\nOrganize sales and marketing efforts by identifying the best opportunities for the AS market.\n<\/li>\n<li>\nTo understand the future market competition in the AS market.\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5574388\/ankylosing-spondylitis-as-market-insights?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=rm9zkl&amp;utm_campaign=1723715+-+Global+Ankylosing+Spondylitis+Market+to+2032+-+Featuring+AbbVie%2C+Pfizer%2C+Janssen+Biotech+and+Novartis+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/1h4wla<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;t&#111;&#58;&#x70;&#x72;e&#115;&#x73;&#x40;r&#101;&#115;&#x65;&#x61;r&#99;&#x68;&#x61;n&#100;&#109;&#x61;&#x72;k&#101;&#x74;&#x73;&#46;&#99;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">p&#114;&#x65;&#x73;s&#64;&#114;&#x65;&#x73;e&#97;&#114;&#x63;&#x68;a&#110;&#x64;&#x6d;&#x61;r&#107;&#x65;&#x74;s&#46;&#99;&#x6f;&#x6d;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Ankylosing Spondylitis (AS) &#8211; Market Insights, Epidemiology, and Market Forecast &#8211; 2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report delivers an in-depth understanding of the AS, historical and forecasted epidemiology as well as the AS market trends in the United States, , EU5 (Germany, France, Italy, Spain, and the United Kingdom), &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45992","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Ankylosing Spondylitis Market to 2032 - Featuring AbbVie, Pfizer, Janssen Biotech and Novartis Among Others - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Ankylosing Spondylitis Market to 2032 - Featuring AbbVie, Pfizer, Janssen Biotech and Novartis Among Others - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Ankylosing Spondylitis (AS) &#8211; Market Insights, Epidemiology, and Market Forecast &#8211; 2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report delivers an in-depth understanding of the AS, historical and forecasted epidemiology as well as the AS market trends in the United States, , EU5 (Germany, France, Italy, Spain, and the United Kingdom), ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-08T16:01:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220708005405\/en\/1508350\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Ankylosing Spondylitis Market to 2032 &#8211; Featuring AbbVie, Pfizer, Janssen Biotech and Novartis Among Others &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-07-08T16:01:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\\\/\"},\"wordCount\":778,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220708005405\\\/en\\\/1508350\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\\\/\",\"name\":\"Global Ankylosing Spondylitis Market to 2032 - Featuring AbbVie, Pfizer, Janssen Biotech and Novartis Among Others - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220708005405\\\/en\\\/1508350\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-07-08T16:01:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220708005405\\\/en\\\/1508350\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220708005405\\\/en\\\/1508350\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Ankylosing Spondylitis Market to 2032 &#8211; Featuring AbbVie, Pfizer, Janssen Biotech and Novartis Among Others &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Ankylosing Spondylitis Market to 2032 - Featuring AbbVie, Pfizer, Janssen Biotech and Novartis Among Others - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Ankylosing Spondylitis Market to 2032 - Featuring AbbVie, Pfizer, Janssen Biotech and Novartis Among Others - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Ankylosing Spondylitis (AS) &#8211; Market Insights, Epidemiology, and Market Forecast &#8211; 2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report delivers an in-depth understanding of the AS, historical and forecasted epidemiology as well as the AS market trends in the United States, , EU5 (Germany, France, Italy, Spain, and the United Kingdom), ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-08T16:01:36+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220708005405\/en\/1508350\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Ankylosing Spondylitis Market to 2032 &#8211; Featuring AbbVie, Pfizer, Janssen Biotech and Novartis Among Others &#8211; ResearchAndMarkets.com","datePublished":"2022-07-08T16:01:36+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\/"},"wordCount":778,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220708005405\/en\/1508350\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\/","name":"Global Ankylosing Spondylitis Market to 2032 - Featuring AbbVie, Pfizer, Janssen Biotech and Novartis Among Others - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220708005405\/en\/1508350\/21\/logo.jpg","datePublished":"2022-07-08T16:01:36+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220708005405\/en\/1508350\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220708005405\/en\/1508350\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-ankylosing-spondylitis-market-to-2032-featuring-abbvie-pfizer-janssen-biotech-and-novartis-among-others-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Ankylosing Spondylitis Market to 2032 &#8211; Featuring AbbVie, Pfizer, Janssen Biotech and Novartis Among Others &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45992","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45992"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45992\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45992"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45992"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45992"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}